New York Medical College
Clinical trials sponsored by New York Medical College, explained in plain language.
-
Immune cell therapy trial offers new hope for young hodgkin lymphoma patients
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children, adolescents, and young adults with a certain type of Hodgkin lymphoma that has come back after initial therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer…
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New CAR T-Cell combo trial targets tough hodgkin lymphoma in youth
Disease control Not yet recruitingThis trial tests whether giving CD30-targeting CAR T-cells after a strong chemotherapy and stem cell transplant is safe and feasible for children, teens, and young adults with poor-risk classical Hodgkin lymphoma. About 21 participants aged 6 to 29 will receive the treatment. The…
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immune cell boost may help kids beat Post-Transplant viruses
Disease control Not yet recruitingThis study tests whether adding immune cells from a family donor to standard antiviral drugs can help children and young adults clear stubborn adenovirus or cytomegalovirus infections after a stem cell transplant. About 69 participants will be randomly assigned to receive either …
Phase: PHASE3 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC